evidence: Shared antigen vaccines target antigens commonly expressed across multiple cancer types compared to personalized cancer vaccines targeting specific mutations in an individual’s tumor, making them off-the-shelf and low-cost immunotherapies. [...] Sahin, U. et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature547, 222–226 (2017).